Concepedia

Subhas Bhowmick

SB

Statistics

Publications

9

Citations

259

H-Index

9

Active since

2017

Affiliations

Sun Pharma Advanced Research (India)(Current)

Maharaja Sayajirao University of Baroda

Narsee Monjee Institute of Management Studies

Subhas Bhowmick is an author at Sun Pharma Advanced Research (India) specializing in drug delivery, pharmacology, and liposomal formulations.

Publications per year

2017–2022

9

Publications

9

Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models

Vinod Burade, Subhas Bhowmick, Kuntal Maiti et al. · BMC Cancer · 2017 · 61 citations · Full text

, , +14

Synergistic co-loading of vincristine improved chemotherapeutic potential of pegylated liposomal doxorubicin against triple negative breast cancer and non-small cell lung cancer

Saikat Ghosh, Rohan Lalani, Kuntal Maiti et al. · Nanomedicine Nanotechnology Biology and Medicine · 2020 · 51 citations

, , +15

Two multicenter Phase I randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Doxil® or Caelyx® in advanced ovarian cancer

Shravanti Bhowmik, Subhas Bhowmick, Kuntal Maiti et al. · Cancer Chemotherapy and Pharmacology · 2018 · 35 citations

, , +13

Injectable drug delivery systems of doxorubicin revisited: In vitro-in vivo relationships using human clinical data

Harshvardhan Modh, Daniel Juncheng Fang, Yi Ou et al. · International Journal of Pharmaceutics · 2021 · 28 citations

, , +16

Optimization and Efficacy Study of Synergistic Vincristine Coloaded Liposomal Doxorubicin Against Breast and Lung Cancer

Saikat Ghosh, Rohan Lalani, Kuntal Maiti et al. · Nanomedicine · 2020 · 22 citations

, , +17

1–5 of 9